English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
NCRI presentation: Better clinical trials
Share :
NCRI
4 - 7 Oct 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
8 Dec 2009
Views:
11394
Rating:
Save
Rate video
Prof Ian F Tannock, Princess Margaret hospital and University of Toronto
Evolution of the cancer clinical trial over three decades: problems of design, analysis, reporting and interpretation.
Categories:
Drug development
Related Videos
Preview: World Cancer Congress 2024
Union for International Cancer Control
17 Jul 2024
Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful...
Dr Do-Youn Oh - Seoul National University Hospital, Seoul, Korea
15 Jul 2024
Biomarkers, Predictive and Prognostic Factors of Resistance to Immunotherapy
Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)...
12 Jul 2024
Gastrointestinal Tumors
Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA
12 Jul 2024
GIST Tumors and Soft Tissue Sarcomas
Dr Atif Hussein - Memorial Cancer Institute, Miami, USA
12 Jul 2024
Hormonal Receptor Positive Breast Cancer Adjuvant and Metastatic Indications
Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA
12 Jul 2024
Antibody Drug Conjugates Coming to Primetime and New Agents for Breast Cancer
Dr Mariana Chavez McGregor - MD Anderson Cancer Center, Houston, USA
12 Jul 2024
Intervention of Osteoclastogenesis that Occurs in Breast Cancer and Multiple...
Dr Gregg Fields - Florida Atlantic University, Florida, USA
12 Jul 2024
Uncommon Genetic Aberrations NTRK, RET, NRG
Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA
12 Jul 2024
More from
e
cancer